AtmosClear Investments
VC Fund
Lausanne, Switzerland
AtmosClear Investments is a VC fund in Lausanne focused on Health Care and Software. AtmosClear SA is a venture capital firm specializing in seed investment. The firm primarily invests in high technology, telecommunication, renewable energy, recycling energy and property development sector. The firm typically make equity investment up to £10 million ($13.20 million). AtmosClear SA was founded in 2002 and is based in Lausanne,Switzerland with an additional office in East Sussex, United Kingdom.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries AtmosClear Investments invests in
Stages AtmosClear Investments invests in
Countries AtmosClear Investments invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Software 1 (33%)
- Power Grid 1 (33%)
- 3D Technology 1 (33%)
- Biotechnology 1 (33%)
Stage
- Seed 2 (67%)
- Venture - Series Unknown 1 (33%)
Country
- Switzerland 2 (67%)
- United Kingdom 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Zaphiro has developed a real-time monitoring and automation system that enhances the efficiency and profitability of grid operations. Moreover, Zaphiro Technologies transforms the electrical distribution grids from passive to pro-active.Zaphiro Technologies is a spin-off of the Swiss Federal Institute of Technology of Lausanne (EPFL). It has beenincorporated in April 2017 and co-founded by 3 researchers: Paolo Romano, Marco Pignati and Lorenzo Zanni. | $1.5M / Seed / Mar 11, 2019 | ||
| Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™. | $2M / Venture - Series Unknown / Aug 01, 2018 | ||
| CREAL develops near-eye light-field display bringing true optical depth and better immersion into virtual and mixed reality.This technology solves the eye-strain, nausea and pain problems of current headsets, while offering low manufacturing complexity and small form factor. | $868.1K / Seed / Jun 06, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does AtmosClear Investments invest in?
AtmosClear Investments invests primarily in Health Care, Software and Power Grid startups, most often at Seed and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did AtmosClear Investments last invest?
The most recent investment recorded for AtmosClear Investments closed in Mar 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
